# OnCo record nevisense (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/nevisense/>
  a schema:MedicalTest ;
  onco:kind "drug" ;
  schema:identifier "nevisense" ;
  schema:name "Nevisense (electrical impedance spectroscopy for melanoma, SciBase)"@en ;
  schema:description "A probe that measures the electrical properties of a worrying mole to give a dermatologist more information before deciding on a biopsy, approved by the FDA in 2017."@en ;
  schema:url <https://onco.cc/drugs/nevisense/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P150046> ;
  onco:status "approved" ;
  onco:tag "test", "screening-test" ;
  onco:modality "Electrical impedance spectroscopy test of skin lesions" ;
  schema:alternateName "Nevisense" ;
  onco:approval "US 2017: Additional information before biopsy of lesions with characteristics of melanoma, for dermatologists (PMA P150046)" ;
  onco:related <https://onco.cc/collections/fda-device-databases/> ;
  onco:cancers <https://onco.cc/cancers/melanoma/> ;
  onco:sections <https://onco.cc/fronts/early-detection/>, <https://onco.cc/fronts/diagnostics/> ;
  onco:technologies <https://onco.cc/technologies/skin-cancer-screening/> ;
  onco:terms <https://onco.cc/terms/screening/> .